These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27942840)

  • 1. Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells.
    Ríos-Huerta R; Monreal-Escalante E; Govea-Alonso DO; Angulo C; Rosales-Mendoza S
    Plant Cell Rep; 2017 Feb; 36(2):355-365. PubMed ID: 27942840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-epitope plant-made chimeric protein (LTBentero) targeting common enteric pathogens is immunogenic in mice.
    Trujillo E; Rosales-Mendoza S; Angulo C
    Plant Mol Biol; 2020 Jan; 102(1-2):159-169. PubMed ID: 31820286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.
    Qiu X; Alimonti JB; Melito PL; Fernando L; Ströher U; Jones SM
    Clin Immunol; 2011 Nov; 141(2):218-27. PubMed ID: 21925951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants.
    Rosales-Mendoza S; Alpuche-Solís AG; Soria-Guerra RE; Moreno-Fierros L; Martínez-González L; Herrera-Díaz A; Korban SS
    Plant J; 2009 Jan; 57(1):45-54. PubMed ID: 18764920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of the VP40 antigen from the Zaire ebolavirus in tobacco plants.
    Monreal-Escalante E; Ramos-Vega AA; Salazar-González JA; Bañuelos-Hernández B; Angulo C; Rosales-Mendoza S
    Planta; 2017 Jul; 246(1):123-132. PubMed ID: 28389867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a multiepitopic Zaire ebolavirus protein and its expression in plant cells.
    Nieto-Gómez R; Angulo C; Monreal-Escalante E; Govea-Alonso DO; De Groot AS; Rosales-Mendoza S
    J Biotechnol; 2019 Apr; 295():41-48. PubMed ID: 30826446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic plants expressing a Clostridium difficile spore antigen as an approach to develop low-cost oral vaccines.
    Rosales-Mendoza S; Cervantes-Rincón T; Romero-Maldonado A; Monreal-Escalante E; Nieto-Gómez R
    Biotechnol Prog; 2021 May; 37(3):e3141. PubMed ID: 33666366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice.
    Xie L; Zai J; Yi K; Li Y
    Vaccine; 2019 May; 37(25):3335-3342. PubMed ID: 31076161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
    Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
    J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.
    Phoolcharoen W; Bhoo SH; Lai H; Ma J; Arntzen CJ; Chen Q; Mason HS
    Plant Biotechnol J; 2011 Sep; 9(7):807-16. PubMed ID: 21281425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody.
    Wang Y; Liu Z; Dai Q
    Virus Res; 2014 Aug; 189():254-61. PubMed ID: 24930448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors.
    Meyer M; Yoshida A; Ramanathan P; Saphire EO; Collins PL; Crowe JE; Samal S; Bukreyev A
    Cell Rep; 2018 Aug; 24(7):1816-1829. PubMed ID: 30110638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2.
    Hazama M; Mayumi-Aono A; Miyazaki T; Hinuma S; Fujisawa Y
    Immunology; 1993 Apr; 78(4):643-9. PubMed ID: 8388365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
    Warfield KL; Olinger G; Deal EM; Swenson DL; Bailey M; Negley DL; Hart MK; Bavari S
    J Immunol; 2005 Jul; 175(2):1184-91. PubMed ID: 16002721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
    Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
    Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
    Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
    PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs.
    Chia MY; Hsiao SH; Chan HT; Do YY; Huang PL; Chang HW; Tsai YC; Lin CM; Pang VF; Jeng CR
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):215-25. PubMed ID: 21277027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.